These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 20339193
1. IL-10 polymorphisms are associated with coronary artery lesions in acute stage of Kawasaki disease. Weng KP, Hsieh KS, Hwang YT, Huang SH, Lai TJ, Yuh YS, Hou YY, Lin CC, Huang SC, Chang CK, Lin MW, Ger LP. Circ J; 2010 May; 74(5):983-9. PubMed ID: 20339193 [Abstract] [Full Text] [Related]
2. [The correlation between Kawasaki disease and polymorphisms of Tumor necrosis factor alpha and interleukin-10 gene promoter]. Yang J, Li CR, Li YB, Li RX, Sun LB, Huang HJ, Wang GB. Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):598-602. PubMed ID: 14744383 [Abstract] [Full Text] [Related]
3. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease. Weng KP, Hsieh KS, Huang SH, Ou SF, Ma CY, Ho TY, Lai CR, Ger LP. Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058 [Abstract] [Full Text] [Related]
4. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease. Weng KP, Hsieh KS, Huang SH, Ou SF, Lai TJ, Tang CW, Lin CC, Ho TY, Liou HH, Ger LP. J Chin Med Assoc; 2013 Aug; 76(8):438-45. PubMed ID: 23769880 [Abstract] [Full Text] [Related]
5. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status. Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H. Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742 [Abstract] [Full Text] [Related]
6. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective? Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR. Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447 [Abstract] [Full Text] [Related]
7. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease. Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y. Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694 [Abstract] [Full Text] [Related]
8. Genetic analysis of MMP gene polymorphisms in patients with Kawasaki disease. Ikeda K, Ihara K, Yamaguchi K, Muneuchi J, Ohno T, Mizuno Y, Hara T. Pediatr Res; 2008 Feb; 63(2):182-5. PubMed ID: 18091353 [Abstract] [Full Text] [Related]
9. The IL-1B Gene Polymorphisms rs16944 and rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease. Fu LY, Qiu X, Deng QL, Huang P, Pi L, Xu Y, Che D, Zhou H, Lu Z, Tan Y, Jiang Z, Zhang L, Liu T, Gu X. J Immunol Res; 2019 Feb; 2019():4730507. PubMed ID: 31093510 [Abstract] [Full Text] [Related]
10. HMGB1 gene polymorphism is associated with coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease. Ahn JG, Bae Y, Shin D, Nam J, Kim KY, Kim DS. Rheumatology (Oxford); 2019 May 01; 58(5):770-775. PubMed ID: 30535242 [Abstract] [Full Text] [Related]
11. Assessment of risk factors for Korean children with Kawasaki disease. Kim JJ, Hong YM, Yun SW, Han MK, Lee KY, Song MS, Lee HD, Kim DS, Sohn S, Ha KS, Hong SJ, Kim KJ, Park IS, Jang GY, Lee JK, Korean Kawasaki Disease Genetics Consortium. Pediatr Cardiol; 2012 Apr 01; 33(4):513-20. PubMed ID: 22105492 [Abstract] [Full Text] [Related]
12. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease. Chen J, Liu P, Hu W, Xu Y, Deng J. Clin Rheumatol; 2021 Oct 01; 40(10):4191-4197. PubMed ID: 34059986 [Abstract] [Full Text] [Related]
13. Major histocompatibility complex class I chain-related gene polymorphisms: associated with susceptibility to Kawasaki disease and coronary artery aneurysms. Hsieh YY, Chang CC, Hsu CM, Chen SY, Lin WH, Tsai FJ. Genet Test Mol Biomarkers; 2011 Nov 01; 15(11):755-63. PubMed ID: 21815799 [Abstract] [Full Text] [Related]
14. BTNL2 gene polymorphisms may be associated with susceptibility to Kawasaki disease and formation of coronary artery lesions in Taiwanese children. Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai FJ. Eur J Pediatr; 2010 Jun 01; 169(6):713-9. PubMed ID: 19882345 [Abstract] [Full Text] [Related]
15. Single-nucleotide polymorphism rs2290692 in the 3'UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population. Peng Q, Chen C, Zhang Y, He H, Wu Q, Liao J, Li B, Luo C, Hu X, Zheng Z, Yang Y. Pediatr Cardiol; 2012 Oct 01; 33(7):1046-53. PubMed ID: 22361738 [Abstract] [Full Text] [Related]
16. Promoter polymorphism (rs3755724, -55C/T) of tissue inhibitor of metalloproteinase 4 (TIMP4) as a risk factor for Kawasaki disease with coronary artery lesions in a Korean population. Ban JY, Yoon KL, Kim SK, Kang S, Chung JH. Pediatr Cardiol; 2009 Apr 01; 30(3):331-5. PubMed ID: 19048177 [Abstract] [Full Text] [Related]
17. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F. Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400 [Abstract] [Full Text] [Related]
18. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study. Nandi A, Pal P, Basu S. Rheumatol Int; 2019 Oct 21; 39(10):1797-1801. PubMed ID: 31302740 [Abstract] [Full Text] [Related]
19. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway. Peng Q, Deng Y, Yang X, Leng X, Yang Y, Liu H. Eur J Pediatr; 2016 May 21; 175(5):705-13. PubMed ID: 26833052 [Abstract] [Full Text] [Related]
20. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease. Wu Y, Wang S, Zhou Y, Yang Y, Li S, Yin W, Ding Y. PLoS One; 2023 May 21; 18(10):e0292653. PubMed ID: 37824465 [Abstract] [Full Text] [Related] Page: [Next] [New Search]